Understanding the Risks of Investing in Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics Inc’s filing revealed that its CMO Donovan Joanne M. unloaded Company’s shares for reported $69627.0 on May 02
Edgewise Therapeutics Inc’s filing revealed that its CMO Donovan Joanne M. unloaded Company’s shares for reported $69627.0 on May 02
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edgewise Therapeutics
Edgewise Therapeutics Inc’s recent filing unveils that its General Counsel MOORE JOHN R unloaded Company’s shares for reported $0.16 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Edgewise Therapeutics Inc’s recent filing unveils that its General Counsel MOORE JOHN R unloaded Company’s shares for reported $0.16 million
Edgewise Therapeutics Inc’s recent filing unveils that its General Counsel MOORE JOHN R unloaded Company’s shares for reported $0.16 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Edgewise Therapeutics Inc’s recently made public that its General Counsel MOORE JOHN R unloaded Company’s shares for reported $0.16 million